Volume 44, Issue 16 pp. 2429-2432
Communication

A Cobaltocenium–Peptide Bioconjugate Shows Enhanced Cellular Uptake and Directed Nuclear Delivery

Fozia Noor

Fozia Noor

Institut für Pharmazie und Molekulare Biotechnologie, Universität Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany, Fax: (+49) 6221-54-64-41

Search for more papers by this author
Annette Wüstholz

Annette Wüstholz

Institut für Pharmazie und Molekulare Biotechnologie, Universität Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany, Fax: (+49) 6221-54-64-41

Search for more papers by this author
Ralf Kinscherf Priv.-Doz. Dr.

Ralf Kinscherf Priv.-Doz. Dr.

Institut für Anatomie und Zellbiologie, Universität Heidelberg, Im Neuenheimer Feld 307, 69120 Heidelberg, Germany

Search for more papers by this author
Nils Metzler-Nolte Prof. Dr.

Nils Metzler-Nolte Prof. Dr.

Institut für Pharmazie und Molekulare Biotechnologie, Universität Heidelberg, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany, Fax: (+49) 6221-54-64-41

Search for more papers by this author
First published: 13 April 2005
Citations: 141

Graphical Abstract

The key to the cells: The N-terminal organometallic complex shown greatly improves cellular uptake of a bioconjugate containing the NLS peptide (NLS=nuclear localization sequence) and cobaltocenium carboxylic acid. Nuclear localization of this novel organometallic bioconjugate in HepG2 cells is demonstrated by live-cell fluorescence microscopy (see picture). FITC=fluorescein isothiocyanate.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.